Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 315

1.

Fetal valproate syndrome.

Clayton-Smith J, Donnai D.

J Med Genet. 1995 Sep;32(9):724-7. No abstract available.

3.

A case of fetal valproate syndrome with new features expanding the phenotype.

Al-Mendalawi MD, Seidahmed MZ.

Saudi Med J. 2009 Jul;30(7):977; author reply 977-8. No abstract available.

PMID:
19618023
4.

A case of fetal valproate syndrome with new features expanding the phenotype.

Seidahmed MZ, Miqdad AM, Al-Dohami HS, Shareefi OM.

Saudi Med J. 2009 Feb;30(2):288-91.

PMID:
19198722
5.

[Embryofetopathy due to valproate: a pathology only little known. Apropos of 4 cases].

Espinasse M, Manouvrier S, Boute O, Farriaux JP.

Arch Pediatr. 1996 Sep;3(9):896-9. French.

PMID:
8949354
6.

Baller-Gerold syndrome after fetal exposure to sodium valproate.

de Oliveira RS, Lajeunie E, Arnaud E, Greensmith A, Renier D.

Am J Med Genet A. 2005 Apr 1;134A(1):113. No abstract available.

PMID:
15732083
7.

Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality.

Duncan S, Mercho S, Lopes-Cendes I, Seni MH, Benjamin A, Dubeau F, Andermann F, Andermann E.

Epilepsia. 2001 Jun;42(6):750-3.

8.

A case of fetal anticonvulsant syndrome with severe bilateral upper limb defect.

Guven MA, Batukan C, Ceylaner S, Ceylaner G, Uzel M.

J Matern Fetal Neonatal Med. 2006 Feb;19(2):115-7.

PMID:
16676441
9.

Valproate embryopathy in three sets of siblings: further proof of hereditary susceptibility.

Malm H, Kajantie E, Kivirikko S, Kääriäinen H, Peippo M, Somer M.

Neurology. 2002 Aug 27;59(4):630-3.

PMID:
12196666
10.

Fetal valproate embryopathy in twins: genetic modification of the response to a teratogen.

Hockey A, Bower C, Goldblatt J, Knowles S.

Birth Defects Orig Artic Ser. 1996;30(1):401-5. No abstract available.

PMID:
9125345
11.

[Fetal valproate syndrome].

Taubøll E, Gjerstad L, Henriksen T, Husby H.

Tidsskr Nor Laegeforen. 2003 Oct 9;123(19):2765. Norwegian. No abstract available.

12.

[The dangers of valproate in women].

Isojärvi J.

Duodecim. 1998;114(9):825, 827. Finnish. No abstract available.

PMID:
11524801
13.

Congenital malformations associated with maternal use of valproic acid.

Huot C, Gauthier M, Lebel M, Larbrisseau A.

Can J Neurol Sci. 1987 Aug;14(3):290-3. Review.

PMID:
3117346
14.

Sodium valproate in pregnancy.

Orrell RW.

BMJ. 1991 Jul 6;303(6793):56-7. No abstract available.

15.

Teratogenicity of sodium valproate.

Alsdorf R, Wyszynski DF.

Expert Opin Drug Saf. 2005 Mar;4(2):345-53. Review.

PMID:
15794725
16.

[Fetal valproate syndrome].

Sonoda T.

Ryoikibetsu Shokogun Shirizu. 2000;(30 Pt 5):96-8. Review. Japanese. No abstract available.

PMID:
11057157
17.

In-utero exposure to valproate and neural tube defects.

Lindhout D, Schmidt D.

Lancet. 1986 Jun 14;1(8494):1392-3. No abstract available.

PMID:
2872511
18.

Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate.

Craig J, Morrison P, Morrow J, Patterson V.

Seizure. 1999 Jun;8(4):253-4. No abstract available.

19.

Spectrum of neural-tube defects in 34 infants prenatally exposed to antiepileptic drugs.

Lindhout D, Omtzigt JG, Cornel MC.

Neurology. 1992 Apr;42(4 Suppl 5):111-8.

PMID:
1574164
20.

Holoprosencephaly and the teratogenicity of anticonvulsants.

Holmes LB, Harvey EA.

Teratology. 1994 Feb;49(2):82. No abstract available.

PMID:
8016748

Supplemental Content

Support Center